ALEMBIC
Back to Income Statement
|
ALEMBIC Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹311 Cr | ₹269 Cr | ₹191 Cr | ₹222 Cr | ₹343 Cr |
What is the latest Consolidated Net Profit of ALEMBIC ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹311 Cr |
| Mar2024 | ₹269 Cr |
| Mar2023 | ₹191 Cr |
| Mar2022 | ₹222 Cr |
| Mar2021 | ₹343 Cr |
How is Consolidated Net Profit of ALEMBIC Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹311 Cr | 15.66 | |
| Mar2024 | ₹269 Cr | 40.90 | |
| Mar2023 | ₹191 Cr | -14.14 | |
| Mar2022 | ₹222 Cr | -35.23 | |
| Mar2021 | ₹343 Cr | - | |
Compare Consolidated Net Profit of peers of ALEMBIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC | ₹2,036.2 Cr | -5.7% | -18.2% | -24.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,645.0 Cr | -1.5% | 1.6% | 1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,625.0 Cr | -2% | -4.3% | 3.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,415.0 Cr | -0.8% | 0.5% | 32% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,664.0 Cr | -2.7% | -1.6% | 6.9% | Stock Analytics | |
| CIPLA | ₹100,480.0 Cr | -3.9% | -9.1% | -18.4% | Stock Analytics | |
ALEMBIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC | -5.7% |
-18.2% |
-24.1% |
| SENSEX | -1.9% |
-9.1% |
-0.2% |
You may also like the below Video Courses